Device Week, 4 October 2019 – Demant Group Recovers From Cyber-Attack; TCT Conference Highlights

In this edition of Device Week, reporter Catherine Longworth provides an update on how Demant Group is recovering from a ransomware attack that forced the Danish hearing aid manufacturer to shut down its IT systems. Deputy editor Reed Miller reviews the highlights from the clinical trial presentations at the recent Transcatheter Cardiovascular Therapeutics conference in San Francisco. Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: Market Intel: Hearing-Aid Companies' Use Of AI, Apps, New Tech Excites Audiologists; Global Hearing-Aid Market Will Reach $11Bn By 2023 http://bit.ly/2McmTyt TCT 2019: Boston Scientific's Acurate Neo TAVR Misses Endpoint In SCOPE I http://bit.ly/2Ovf61B TCT 2019: New COAPT Results Support, Durability And Cost-Effectiveness Of Abbott’s MitraClip http://bit.ly/2pnjDIV TCT 2019: IDEAL LM Inconclusive, While Onyx ONE Boosts Polymer-Based DES http://bit.ly/2nm1QkC TCT 2019: Evolve Short DAPT And Model U-SUS Study Show Short DAPT Was Comparable To Longer-Term DAPT http://bit.ly/2LJXNb3 TCT 2019: Five-Year PARTNER 2A Results Support TAVR In Most Intermediate Risk Patients http://bit.ly/2MhYZS0 TCT 2019: TRILUMINATE Six-Month Results Support Abbott’s TriClip http://bit.ly/3317Azi TCT 2019: One-Year PARTNER 3 Outcomes Show Better Quality Of Life With TAVR http://bit.ly/35a6V0b